PER 2.47% 8.3¢ percheron therapeutics limited

Not forgetting Kynamro, Sanofi's report released...

  1. 3,331 Posts.
    lightbulb Created with Sketch. 164
    Not forgetting Kynamro, Sanofi's report released
    http://en.sanofi.com/Images/36956_20140730_q2results_en.pdf
    Kynamro as far as I can see does not get a mention.  However in the Genzyme section Lemtrada for MS gets a half year total of $11M.  Has Genzyme given up on Kynamro?

    I'll say it once again, ISIS needs validation of its platform and what better to give it to them, ANP's 1103 and 1102.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.3¢
Change
0.002(2.47%)
Mkt cap ! $74.82M
Open High Low Value Volume
9.0¢ 9.0¢ 8.2¢ $9.57K 112.6K

Buyers (Bids)

No. Vol. Price($)
2 124862 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 11000 1
View Market Depth
Last trade - 15.56pm 28/03/2024 (20 minute delay) ?
Last
8.2¢
  Change
0.002 ( 0.86 %)
Open High Low Volume
8.2¢ 8.3¢ 8.2¢ 31700
Last updated 15.55pm 28/03/2024 ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.